Convalescent Plasma News and Research

RSS
Study explores adverse effects of SARS-CoV-2-induced antibody responses

Study explores adverse effects of SARS-CoV-2-induced antibody responses

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Comparing effectiveness of virus and patients-centered strategies to reduce COVID-19 mortality

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Rapid finger stick test to detect antibodies against SARS-CoV-2 variants

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

The SARS-CoV-2 Beta variant evades Fc effector function by ancestral strain, study says

The SARS-CoV-2 Beta variant evades Fc effector function by ancestral strain, study says

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses

Antibody response of COVID-19 patients to SARS-CoV-2 and seasonal coronaviruses

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

SARS-CoV-2 neutralizing antibodies discovered in a 20-year-old human antibody library

Isolation of potent neutralizing monoclonal antibodies using nanoparticles displaying SARS-CoV-2 S glycoprotein

Isolation of potent neutralizing monoclonal antibodies using nanoparticles displaying SARS-CoV-2 S glycoprotein

SARS-CoV-2 variants neutralized by camel nanobodies

SARS-CoV-2 variants neutralized by camel nanobodies

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

Emerging SARS-CoV-2 variant A.30 efficiently evades vaccine-induced immunity

New Canadian serology solution for SARS-CoV-2 infections and vaccination

New Canadian serology solution for SARS-CoV-2 infections and vaccination

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

SARS-CoV-2 cocktail with three antibodies potent in preclinical testing

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

Serologic testing algorithm to detect disparities in SARS-CoV-2 infection prevalence and vaccination uptake

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

Ondansetron use associated with increased survival in mechanically ventilated COVID-19 patients

Accumulation of SARS-CoV-2 mutations reduces sensitivity to neutralizing antibodies

Accumulation of SARS-CoV-2 mutations reduces sensitivity to neutralizing antibodies

Powerful neutralizing antibody against SARS-CoV-2 variants of concern

Powerful neutralizing antibody against SARS-CoV-2 variants of concern